Diversity and Inclusion in Clinical Trial Participation

At Merck KGaA, Darmstadt, Germany, we are committed to developing treatments that meet the needs of our diverse patients. To do so, we fully acknowledge the importance of adequately representing diverse participants in our clinical studies to ensure assessment of safety and efficacy of our drugs across different patient populations.

To learn more about our approach to achieve fair and equitable enrollment of diverse patients into our clinical studies, please make sure to click here to read our full Commitment on Diversity, Equity, and Inclusion in Clinical Study Participation.